MedPath

Amyloid Accumulation After Mild Traumatic Brain Injury

Phase 2
Conditions
Traumatic Brain Injury
Interventions
Drug: [18F]AV-45 PET amyloid binding imaging
Registration Number
NCT01871610
Lead Sponsor
Chang Gung Memorial Hospital
Brief Summary

There will be 200 participants, who aged 30 years or older with TBI in 1,5,10,15 years ago and GCS=13-15 will be recruited. Another group of 200 participants with the same age and gender and without TBI will be recruited as the controls. All of them will undergo AD8 questionnaire for dementia screening and APOE4 genotyping. Further CASI and CDR will be tested for the confirmation of dementia diagnosis for the individuals with AD8 scaore \>/=2. 10 TBI with dementia, 20 TBI without dementia and 10 controls will be selected randomly for AV45 amylid PET study.

There will also be 10 participants without traumatic brain injury and interested in this study, aged 55 years or older better.

Detailed Description

We will examine the mTBI patients in a long-term follow-up manner by cognitive tests and A-PET. This is a novel study for linking mTBI and AD by solid, reliable methods, in terms of A-PET and cognitive function tests. In addition, we will figure out the importance of APOE genotypes for amyloid accumulation and cognitive impairment. These results should shed light on the further clinical studies and amyloid-cleaning therapy for prevention and treatment for dementia after mTBI.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
mild traumatic brain injury without Alzheimer disease[18F]AV-45 PET amyloid binding imagingTo recruit patients 1, 5, 10, 15 years after mTBI with or without cognitive impairment and age-gender-matched controls (a total of 3 groups) for amyloid- positron emission tomography (A-PET)
Alzheimer disease after mild traumatic brain injury[18F]AV-45 PET amyloid binding imagingBased on the TBI registry databank, to recruit patients 1, 5, 10, 15 years after mTBI for cognitive evaluatio
Normal control[18F]AV-45 PET amyloid binding imagingPeople aged 30 or older without mTBI or AD
Primary Outcome Measures
NameTimeMethod
The amyloids load in brain among mild traumatic brain injury and controls in a temporal manner.one year

The amyloids load (based on F-18-AV-45 binding) in brain among mild traumatic brain injury and controls in a temporal manner.

Secondary Outcome Measures
NameTimeMethod
F-18-AV-45 binding changes and cognitive function among mild traumatic brain injury and controlsone year

To evaluate the the F-18-AV-45 binding in different APOE genotypes among mild traumatic brain injury and controls

© Copyright 2025. All Rights Reserved by MedPath